AvenCell Therapeutics receives IND clearance and CTA approval for AVC-203 for the treatment of relapsed/refractory B-cell malignancies

Eli Lilly's Jaypirca receives FDA approval for treatment of adults with relapsed or refractory CLL/SLL previously treated with covalent BTK inhibitor

Avetra unveils site-centric CRO operating model

Spinogenix reports approval of 'tazbentetol' as non-proprietary name for SPG302

Xeris Biopharma receives USPTO Notice of Allowance for XP-8121 patent

Ionis Pharmaceuticals granted FDA Breakthrough Therapy Designation for olezarsen in severe hypertriglyceridemia

Polarean expands XENOVIEW 3T Coil access with Philips compatibility

Avandra Health acquires DatCard Systems and Sorna Corporation

Zentiva receives ESG Transparency Award 2025

Immedica gets UAE approval for Zepzelca maintenance treatment

Imugene Ltd enters co-development collaboration with JW Therapeutics (Shanghai)

Sichuan Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy clinical study results published in Annals of Oncology

Kedrion's investigational treatment for Congenital Aceruloplasminemia receives European Orphan Drug Designation

Workit Health Reopens Services in California, Expanding Statewide Access to Virtual Opioid and Alcohol Treatment

Gan & Lee Pharmaceuticals launches third phase 3 trial of once-monthly bofanglutide